Info: Read More
  • 中药标准品生产商,产品定制服务
  • (-)-表没食子儿茶素

    (-)-Epigallocatechin(EGC)

    (-)-表没食子儿茶素
    产品编号 CFN97549
    CAS编号 970-74-1
    分子式 = 分子量 C15H14O7 = 306.3
    产品纯度 >=98%
    物理属性 Powder
    化合物类型 Flavonoids
    植物来源 The herbs of Berchemia kulingensis Schneid.
    ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用
    提供自定义包装
    产品名称 产品编号 CAS编号 包装 QQ客服
    (-)-表没食子儿茶素 CFN97549 970-74-1 10mg QQ客服:3257982914
    (-)-表没食子儿茶素 CFN97549 970-74-1 20mg QQ客服:3257982914
    (-)-表没食子儿茶素 CFN97549 970-74-1 50mg QQ客服:3257982914
    (-)-表没食子儿茶素 CFN97549 970-74-1 100mg QQ客服:3257982914
    存储与注意事项
    1. 在您收到产品后请检查产品。如无问题,请将产品存入冰霜并且样品瓶保持密封,产品可以存放长达24个月(2-8摄氏度)。

    2. 只要有可能,产品溶解后,您应该在同一天应用于您的实验。 但是,如果您需要提前做预实验,或者需要全部溶解,我们建议您将溶液以等分试样的形式存放在-20℃的密封小瓶中。 通常,这些可用于长达两周。 使用前,打开样品瓶前,我们建议您将产品平衡至室温至少1小时。

    3. 需要更多关于溶解度,使用和处理的建议? 请发送电子邮件至:service@chemfaces.com
    订购流程
  • 1. 在线订购
  • 请联系我们QQ客服

  • 2. 电话订购
  • 请拨打电话:
    027-84237683 或 027-84237783

  • 3. 邮件或传真订购
  • 发送电子邮件到: manager@chemfaces.com 或
    发送传真到:027-84254680

  • 提供订购信息
  • 为了方便客户的订购,请需要订购ChemFaces产品的客户,在下单的时候请提供下列信息,以供我们快速为您建立发货信息。
  •  
  • 1. 产品编号(CAS No.或产品名称)
  • 2. 发货地址
  • 3. 联系方法 (联系人,电话)
  • 4. 开票抬头 (如果需要发票的客户)
  • 5. 发票地址(发货地址与发票地址不同)
  • 发货时间
    1. 付款方式为100%预付款客户,我们将在确认收到货款后当天或1-3个工作日发货。

    2. 付款方式为月结的客户,我们承诺在收到订单后当天或1-3个工作日内发货。

    3. 如果客户所需要的产品,需要重新生产,我们有权告知客户,交货时间需要延期。
    ChemFaces的产品在许多优秀和顶级科学期刊中被引用

    Cell. 2018 Jan 11;172(1-2):249-261.e12.
    doi: 10.1016/j.cell.2017.12.019.
    IF=36.216(2019)

    PMID: 29328914

    Cell Metab. 2020 Mar 3;31(3):534-548.e5.
    doi: 10.1016/j.cmet.2020.01.002.
    IF=22.415(2019)

    PMID: 32004475

    Mol Cell. 2017 Nov 16;68(4):673-685.e6.
    doi: 10.1016/j.molcel.2017.10.022.
    IF=14.548(2019)

    PMID: 29149595

    ACS Nano. 2018 Apr 24;12(4): 3385-3396.
    doi: 10.1021/acsnano.7b08969.
    IF=13.903(2019)

    PMID: 29553709

    Nature Plants. 2016 Dec 22;3: 16206.
    doi: 10.1038/nplants.2016.205.
    IF=13.297(2019)

    PMID: 28005066

    Sci Adv. 2018 Oct 24;4(10): eaat6994.
    doi: 10.1126/sciadv.aat6994.
    IF=12.804(2019)

    PMID: 30417089
    我们的产品现已经出口到下面的研究机构与大学,并且还在增涨
  • The Institute of Cancer Research (United Kingdom)
  • University of Limpopo (South Africa)
  • Tokyo Woman's Christian University (Japan)
  • Vin?a Institute of Nuclear Sciences (Serbia)
  • Institute of Bioorganic Chemistry Polish Academy of Sciences (Poland)
  • University of Medicine and Pharmacy (Romania)
  • Uniwersytet Medyczny w ?odzi (Poland)
  • University of Amsterdam (Netherlands)
  • Johannes Gutenberg University Mainz (JGU) (Germany)
  • Guangzhou Institutes of Biomedicine and Health (China)
  • Kitasato University (Japan)
  • Stanford University (USA)
  • Seoul National University (Korea)
  • University of Leipzig (Germany)
  • More...
  • 国外学术期刊发表的引用ChemFaces产品的部分文献
  • Korean Journal of Pharmacognosy2017, 48(4):320-328
  • Life Sci.2019, 216:259-270
  • Neurochem Res.2021, s11064-021-03449-0
  • Antioxidants (Basel).2020, 9(2):E120
  • Environ Toxicol.2021, doi: 10.1002
  • J Mol Recognit.2020, 33(2):e2819
  • Front Microbiol.2019, 10:2806
  • Molecules.2018, 23(2)
  • Phytochemistry.2017, 141:162-170
  • Journal of Functional Foods2019, 52:430-441
  • Int J Mol Sci.2022, 23(23):14826.
  • Journal of Food Hygiene and Safety2019, 34(5):413-420
  • Nutrients.2018, 11(1):E17
  • Life Sci.2023, 317:121458.
  • Neurotox Res.2020, 38(1):163-174.
  • Clin Exp Pharmacol Physiol.2020, doi: 10.1111
  • RSC Adv.2018, 32621-32636
  • Current Pharmaceutical Analysis2017, 13(5)
  • Int J Mol Sci.2022, 23(11):6172.
  • Plants (Basel).2021, 10(2):278.
  • University of Guelph2021, 12.
  • Dicle Tip Dergisi2020, 47(2),423-430.
  • VNU Journal of Science2023, No. 20.
  • ...
  • 生物活性
    Description: (-)-Epigallocatechin exhibits antiplatelet,anticoagulation,anti-tumor,anti-cancer and anti-inflammatory functions. Epigallocatechin activates haem oxygenase-1 expression via protein kinase Cdelta and Nrf2. Cu(2+) with (-)-epigallocatechin (EGC) facilitated DNA cleavage, while Ag+ with EGC showed a strong repressive effect.
    Targets: LDL | NO | HO-1
    In vitro:
    Arch Microbiol. 2014 Oct;196(10):681-95.
    Isolation and characterization of rat intestinal bacteria involved in biotransformation of (-)-epigallocatechin.[Pubmed: 24947740]
    Two intestinal bacterial strains MT4s-5 and MT42 involved in the degradation of (-)-Epigallocatechin(EGC) were isolated from rat feces.
    METHODS AND RESULTS:
    Strain MT4s-5 was tentatively identified as Adlercreutzia equolifaciens. This strain converted (-)-Epigallocatechin(EGC) into not only 1-(3, 4, 5-trihydroxyphenyl)-3-(2, 4, 6-trihydroxyphenyl)propan-2-ol (1), but also 1-(3, 5-dihydroxyphenyl)-3-(2, 4, 6-trihydroxyphenyl)propan-2-ol (2), and 4'-dehydroxylated (-)-Epigallocatechin(EGC) (7). Type strain (JCM 9979) of Eggerthella lenta was also found to convert (-)-Epigallocatechin(EGC) into 1. Strain MT42 was identified as Flavonifractor plautii and converted 1 into 4-hydroxy-5-(3, 4, 5-trihydroxyphenyl)valeric acid (3) and 5-(3, 4, 5-trihydroxyphenyl)-γ-valerolactone (4) simultaneously. Strain MT42 also converted 2 into 4-hydroxy-5-(3, 5-dihydroxyphenyl)valeric acid (5), and 5-(3, 5-dihydroxyphenyl)-γ-valerolactone (6). Furthermore, F. plautii strains ATCC 29863 and ATCC 49531 were found to catalyze the same reactions as strain MT42. Interestingly, formation of 2 from (-)-Epigallocatechin(EGC) by strain MT4s-5 occurred rapidly in the presence of hydrogen supplied by syntrophic bacteria. Strain JCM 9979 also formed 2 in the presence of the hydrogen or formate. Strain MT4s-5 converted 1, 3, and 4 to 2, 5, and 6, respectively, and the conversion was stimulated by hydrogen, whereas strain JCM 9979 could catalyze the conversion only in the presence of hydrogen or formate.
    CONCLUSIONS:
    On the basis of the above results together with previous reports, the principal metabolic pathway of (-)-Epigallocatechin(EGC) and EGCg by catechin-degrading bacteria in gut tract is proposed.
    Febs Letters, 1997, 401(2-3):230-234.
    Green tea catechins suh α(–)-epicatechin and (–)-epigallocatechin accelerate Cu2+-induced low density lipoprotein in propagation phase[Reference: WebLink]

    METHODS AND RESULTS:
    Effects of (-)-epicatechin (EC) and (-)-Epigallocatechin(EGC) on Cu2+-induced low density lipoprotein (LDL) oxidation were studied in initiation and propagation phases. When 1.5 microM EC or EGC was added to the mixture of isolated human LDL and Cu2+ in the initiation phase, the oxidation of LDL was inhibited in agreement with previous findings. In contrast, in the propagation phase, 1.5 microM of EC or EGC worked as an accelerator of the oxidation, and acceleration ratios (maximum about 6 times) were modified depending on the concentrations of catechin used and the oxidation process in the propagation phase. The evidence was obtained from formation of thiobarbituric acid reactive substances (TBARS), detecting conjugated diene measured by absorbance at 234 nm and investigating fragmentation of apoprotein B (apo B) in LDL. Even in the propagation phase of LDL oxidation, the elevated concentrations of EC or EGC worked as inhibitors: after 40 min incubation of LDL with Cu2+, 10.0 microM EC or 2.0 microM EGC inhibited LDL oxidation. Yet, nitric oxide (NO) released from 5 microM zwitterionic polyamine/NO adducts had an inhibitory in all phases of LDL oxidation.
    CONCLUSIONS:
    These results indicate that catechins such as EC and EGC can act as free radical terminators (reducing agents) or accelerators (oxidizing agents) under oxidation circumstances, which is a different character from NO. From the above evidence, further investigations are needed on many natural flavonoids, the most potent antioxidative compounds in foods.
    Biosci Biotechnol Biochem. 1999 Sep;63(9):1654-6.
    DNA cleavage activities of (-)-epigallocatechin, (-)-epicatechin, (+)-catechin, and (-)-epigallocatechin gallate with various kinds of metal ions.[Pubmed: 10610127]
    The DNA cleavage activities of (+)-catechin (C), (-)-epicatechin (EC), (-)-Epigallocatechin(EGC), and (-)-epigallocatechin gallate (EGCg) were examined with 16 different metal ions. Cu(2+) with all the catechins facilitated DNA cleavage, while Ag+ with EGC and EC showed a strong repressive effect. The other metal ions examined showed little effect.
    J Agric Food Chem . 2015 Feb 11;63(5):1347-51.
    (-)-epigallocatechin-3-gallate inhibits fibrillogenesis of chicken cystatin[Pubmed: 25620201]
    Previous studies have reported that (-)-epigallocatechin-3-gallate (EGCG), the most abundant flavonoid in green tea, can bind to unfolded native polypeptides and prevent conversion to amyloid fibrils. To elucidate whether this antifibril activity is specific to disease-related target proteins or is more generic, we investigated the ability of EGCG to inhibit amyloid fibril formation of amyloidogenic mutant chicken cystatin I66Q, a generic amyloid-forming model protein that undergoes fibril formation through a domain swapping mechanism. We demonstrated that EGCG was a potent inhibitor of amyloidogenic cystatin I66Q amyloid fibril formation in vitro. Computational analysis suggested that EGCG prevented amyloidogenic cystatin fibril formation by stabilizing the molecule in its native-like state as opposed to redirecting aggregation toward disordered and amorphous aggregates. Therefore, although EGCG appears to be a generic inhibitor of amyloid-fibril formation, the mechanism by which it achieves such inhibition may be specific to the target fibril-forming polypeptide.
    Anticancer Res . 2015 Jan;35(1):39-46.
    Curcumin and epigallocatechin gallate inhibit the cancer stem cell phenotype via down-regulation of STAT3-NFκB signaling[Pubmed: 25550533]
    Abstract Background/aim: The cancer stem cell (CSC) model postulates the existence of a small proportion of cancer cells capable of sustaining tumor formation, self-renewal and differentiation. Signal Transducer and Activator of Transcription 3 (STAT3) signaling is known to be selectively activated in breast CSC populations. However, it is yet to be determined which molecular mechanisms regulate STAT3 signaling in CSCs and what chemopreventive agents are effective for suppressing CSC growth. The aim of this study was to examine the potential efficacy of curcumin and epigallocatechin gallate (EGCG) against CSC and to uncover the molecular mechanisms of their anticancer effects. Materials and methods: To suppress the CSC phenotype, two breast cancer cell lines (MDA-MB-231 cells and MCF7 cells transfected with HER2) were treated with curcumin (10 μM) with or without EGCG (10 μM) for 48 h. We used tumor-sphere formation and wound-healing assays to determine CSC phenotype. To quantify CSC populations, Fluorescence-activated cell sorting profiling was monitored. STAT3 phosphorylation and interaction with Nuclear Factor-kB (NFkB) were analyzed by performing western blot and immunoprecipitation assays. Results: Combined curcumin and EGCG treatment reduced the cancer stem-like Cluster of differentiation 44 (CD44)-positive cell population. Western blot and immunoprecipitation analyses revealed that curcumin and EGCG specifically inhibited STAT3 phosphorylation and STAT3-NFkB interaction was retained. Conclusion: This study suggests that curcumin and EGCG function as antitumor agents for suppressing breast CSCs. STAT3 and NFκB signaling pathways could serve as targets for reducing CSCs leading to novel targeted-therapy for treating breast cancer.
    Arch Oral Biol . 2015 Mar;60(3):393-9.
    Effects of Epigallocatechin gallate against Enterococcus faecalis biofilm and virulence[Pubmed: 25526623]
    Abstract Objective: Epigallocatechin-3-gallate (EGCG), the most abundant polyphenol in green tea (Camellia sinesis) has been shown to exert antimicrobial effects on numerous bacterial pathogens. However its efficacy against Enterococcus faecalis biofilm, which is associated with persistent root canal infection is unknown. The aims of this study were to investigate the effects of EGCG against E. faecalis biofilm and virulence. Design: Minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) of EGCG on E. faecalis were determined. The efficacy of EGCG on E. faecalis biofilms was tested by exposing 7-day old E. faecalis biofilm to EGCG. Flow cytometry analysis of hydroxyphenyl fluorescein (HPF) labelled E. faecalis was used to determine if EGCG induced intracellular hydroxyl radical formation. Co-treatment of EGCG with the iron chelator 2,2-dipyridyl (DIP) was carried out to determine if hydroxyl radical generated through Fenton reaction played a role in EGCG-mediated killing of E. faecalis. Furthermore, the effects of EGCG on the expression of virulence genes in E. faecalis were evaluated by quantitative polymerase chain reaction. Results: EGCG exhibited a MIC and MBC of 5 μg/mL and 20 μg/mL respectively and effectively eradicated E. faecalis biofilms. EGCG induced the formation of hydroxyl radicals in E. faecalis. The addition of DIP protected E. faecalis against EGCG-mediated antibacterial effects. At sub-MIC, EGCG induced significant down-regulation of E. faecalis virulence genes. Conclusions: EGCG is an effective antimicrobial agent against both the planktonic and biofilm forms of E. faecalis, inhibiting bacterial growth and suppressing the expression of specific genes related to virulence and biofilm formation. The antimicrobial action of EGCG on E. faecalis occurred through the generation of hydroxyl radical.
    In vivo:
    Food Funct. 2013 Oct;4(10):1521-5.
    Blood anticoagulation and antiplatelet activity of green tea (-)-epigallocatechin (EGC) in mice.[Pubmed: 24056410]
    (-)-Epigallocatechin(EGC) was prepared from green tea polyphenols through column chromatography of a polyamide (3.6 × 40 cm).
    METHODS AND RESULTS:
    Three dosages of EGC (0.25, 0.5, 1.0 g kg(-1) d(-1)) were ingested respectively by ICR mice via gavage. Compared with the control group, group (-)-Epigallocatechin(EGC) 0.5 (dosage, 0. 5 g kg(-1) d(-1)) and group (-)-Epigallocatechin(EGC) 1.0 (dosage, 1.0 g kg(-1) d(-1)) presented significant inhibition on platelet aggregation in mice accompanied by 18.4 and 25.6% of inhibition ratio, respectively. The bleeding times (BT) of mice in group (-)-Epigallocatechin(EGC) 0.5 and group EGC1.0 were significantly prolonged (P < 0.01) as well as blood clotting time (BCT) in group (-)-Epigallocatechin(EGC) 1.0 (P < 0.05). All three dosages of EGC prolonged activated partial thromboplastin time (APTT) significantly (P < 0.01), but had no prominent effect on prothrombin time (PT) and fibrinogen level which indicated that the anticoagulation of (-)-Epigallocatechin(EGC) could not be attributed to the level decrease of coagulation factor such as fibrinogen.
    CONCLUSIONS:
    The results demonstrated that EGC had prominent antiplatelet activity and blood anticoagulation in a dose-dependent manner.
    制备储备液(仅供参考)
    1 mg 5 mg 10 mg 20 mg 25 mg
    1 mM 3.2648 mL 16.3239 mL 32.6477 mL 65.2955 mL 81.6193 mL
    5 mM 0.653 mL 3.2648 mL 6.5295 mL 13.0591 mL 16.3239 mL
    10 mM 0.3265 mL 1.6324 mL 3.2648 mL 6.5295 mL 8.1619 mL
    50 mM 0.0653 mL 0.3265 mL 0.653 mL 1.3059 mL 1.6324 mL
    100 mM 0.0326 mL 0.1632 mL 0.3265 mL 0.653 mL 0.8162 mL
    * Note: If you are in the process of experiment, it's need to make the dilution ratios of the samples. The dilution data of the sheet for your reference. Normally, it's can get a better solubility within lower of Concentrations.
    部分图片展示
    产品名称 产品编号 CAS编号 分子式 = 分子量 位单 联系QQ
    3-羟基-4',5,7-三甲氧基黄烷; 3-Hydroxy-4',5,7-trimethoxyflavan CFN95680 3143-21-3 C18H20O5 = 316.4 5mg QQ客服:1413575084
    3,3'-二羟基-4',5,7-三甲氧基黄烷; 3,3'-Dihydroxy-4',5,7-trimethoxyflavan CFN95679 97914-22-2 C18H20O6 = 332.4 5mg QQ客服:2056216494
    3,4'-二羟基-3',5,7-三甲氧基黄烷; 3,4'-Dihydroxy-3,5',7-trimethoxyflavan CFN97558 97914-19-7 C18H20O6 = 332.4 5mg QQ客服:1457312923
    (2R-cis)-2-(1,3-苯并二恶茂-5-基)-3,4-二氢-5,7-二甲氧基-2H-1-苯并吡喃-3-醇; 3-Hydroxy-5,7-dimethoxy-3',4'-methylenedioxyflavan CFN99685 162602-04-2 C18H18O6 = 330.3 5mg QQ客服:2159513211
    表儿茶素; Epicatechin CFN98781 490-46-0 C15H14O6 = 290.3 20mg QQ客服:215959384
    (-)-表儿茶精五乙酸酯; Epicatechin pentaacetate CFN98020 20194-41-6 C25H24O11 = 500.5 5mg QQ客服:1413575084
    表儿茶素没食子酸酯; (-)-Epicatechin gallate CFN99570 1257-08-5 C22H18O10 = 442.38 20mg QQ客服:2159513211
    表儿茶素3-O-(3''-O-甲基)没食子酸酯; (-)-Epicatechin-3-(3''-O-methyl) gallate CFN92080 83104-86-3 C23H20O10 = 456.4 5mg QQ客服:1413575084
    (-)-表没食子儿茶素; (-)-Epigallocatechin(EGC) CFN97549 970-74-1 C15H14O7 = 306.3 20mg QQ客服:215959384
    (-)-表没食子儿茶素没食子酸酯; (-)-Epigallocatechin gallate CFN99569 989-51-5 C22H18O11 = 458.38 20mg QQ客服:2159513211

    信息支持


    公司简介
    订购流程
    付款方式
    退换货政策

    ChemFaces提供的产品仅用于科学研究使用,不用于诊断或治疗程序。

    联系方式


    电机:027-84237783
    传真:027-84254680
    在线QQ: 1413575084
    E-Mail:manager@chemfaces.com

    湖北省武汉沌口经济技术开区车城南路83号1号楼第三层厂房


    ChemFaces为科学家,科研人员与企业提供快速的产品递送。我们通过瑞士SGS ISO 9001:2008质量体系认证天然化合物与对照品的研发和生产